Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FIRST-2.0 China: Finerenone FIRST (Finerenone Research of Early Safety and Effectiveness), Part 2.0 in China

NCT07124039 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT07124039
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07124039 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FIRST-2.0 China: Finerenone FIRST (Finerenone Research of Early Safety and Effectiveness), Part 2.0 in China
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
July 16, 2025
Completion date
February 28, 2026
Enrollment
6,537 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease, type 2 diabetes mellitus